Together with the above results, Rab26 and Rab26b have diverse functions in cancer cells, and Rab26 inhibits the migration and invasion of breast cancer cells through mediating the autophagic degradation of p-Src by interacting with ATG16L1 through its N-terminal region. Here, ATG16L1 is linked to breast carcinoma.